Nautilus Biotechnology, Inc. (NAUT) Form 8-K Material Events
Nautilus Biotechnology, Inc. (NAUT) is a publicly traded company on the Nasdaq, categorized under SIC 3826 (Laboratory Analytical Instruments). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NAUT
CIK: 1808805
Exchange: Nasdaq
SIC 3826: Laboratory Analytical Instruments
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerChristopher Alabi
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-09-18 | — | EFFECT Filing | 9999999995-26-003012 | View SEC Doc Filr Page |
| 424B5 | 2026-09-18 | — | 424B5 | 0001808805-26-000047 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-11 | — | SCHEDULE 13D/A Filing | 0001231919-26-001165 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-11 | 8-K | 0001808805-26-000041 | View SEC Doc Filr Page |
| S-3 | 2026-09-11 | — | S-3 | 0001808805-26-000040 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-28 | — | SCHEDULE 13D/A Filing | 0001725721-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-14 | — | SCHEDULE 13D/A Filing | 0001193125-26-352644 | View SEC Doc Filr Page |
| 10-Q | 2026-07-28 | 2026-06-30 | 10-Q | 0001808805-26-000034 | View SEC Doc Filr Page |
| 8-K | 2026-07-28 | 2026-07-28 | 8-K | 0001808805-26-000030 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-30 | — | SCHEDULE 13D/A Filing | 0001725721-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | FORM 4 | 0001543792-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | FORM 4 | 0001234663-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | FORM 4 | 0001797672-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | FORM 4 | 0001381752-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | FORM 4 | 0001807359-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-17 | 8-K | 0001808805-26-000027 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-04 | — | SCHEDULE 13D/A Filing | 0001725721-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | 4 Filing | 0001231919-26-000599 | View SEC Doc Filr Page |
| ARS | 2026-04-28 | 2025-12-31 | ARS | 0001808805-26-000025 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-28 | — | DEFA14A | 0001808805-26-000024 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-28 | 2026-06-17 | DEF 14A | 0001808805-26-000023 | View SEC Doc Filr Page |
| 10-Q | 2026-04-28 | 2026-03-31 | 10-Q | 0001808805-26-000022 | View SEC Doc Filr Page |
| 8-K | 2026-04-28 | 2026-04-28 | 8-K | 0001808805-26-000015 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-03-04 | — | SCHEDULE 13D/A Filing | 0001378830-26-000005 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-03-04 | — | SCHEDULE 13D/A Filing | 0001857948-26-000003 | View SEC Doc Filr Page |